Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

NCT06064890

Conditions
Aphasia, Aphasia, Primary Progressive, Brain Diseases, +22 more
Locations
  • The Ohio State University (OSU) Wexner Medical Center Columbus, Ohio, United States
  • Vanderbilt University Medical Centre Nashville, Tennessee, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View all 19 locations
View Trial Details
Recruiting

Study of COYA 302 for the Treatment of ALS

NCT07161999

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Nova Southeastern University Davie, Florida, United States
View all 25 locations
View Trial Details
Recruiting

Multicenter ALS Imaging Study

NCT06735014

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Northwestern University Evanston, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684

Conditions
Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Behavioral Variant Frontotemporal Dementia (bvFTD), +41 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 27 locations
View Trial Details

Related conditions